Dr. Hauser is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4001 E Fletcher Ave, 6th Fl
Parkinson's Disease/Movement Disorders Ctr
Tampa, FL 33613Phone+1 813-396-0751Fax+1 813-905-9829- Is this information wrong?
Summary
- Dr. Robert Hauser is Director of the Parkinson's Disease and Movement Disorders Center of the University of South Florida. He received his medical degree from Temple University School of Medicine and has been in practice 31 years. He specializes in Parkinson's disease and is an expert in clinical research to develop new treatments for Parkinson's disease and related disorders. He also performs Botox injections for cervical dystonia, blepharospasm, and hemifacial spasm. He has published over 300 peer reviewed articles and lectures frequently at scientific meetings.
Education & Training
Eastern Virginia Medical SchoolResidency, Neurology, 1983 - 1988
Albert Einstein Medical CenterInternship, Transitional Year, 1982 - 1983
Lewis Katz School of Medicine at Temple UniversityClass of 1982
Certifications & Licensure
FL State Medical License 1989 - 2026
CA State Medical License 1986 - 1992
PA State Medical License 1988 - 1990
MI State Medical License 1988 - 1990- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly
Clinical Trials
- Keppra for Cervical Dystonia Start of enrollment: 2005 Nov 01
- Study of the Application of Magnetic Fields for the Treatment of Parkinson's Disease Start of enrollment: 2009 Mar 01
- Study to Identify Clinical, Imaging and Biologic Markers of Parkinson Disease Progression Start of enrollment: 2010 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis o...Patrício Soares-da-Silva, Kurt Olson, Eric Jen, José-Francisco Rocha, Robert A Hauser, Aleksandar Videnovic, Grace S Liang, Olga Klepitskaya> ;Parkinsonism & Related Disorders. 2024 Apr 9
- Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease.David Stamler, Hadas Barkay, Amanda Wilhelm, Jessica K Alexander, Nayla Chaijale, Steve Barash, Juha-Matti Savola, Samuel Frank, Karen E Anderson, Hubert H Fernandez, ...> ;Neurology and Therapy. 2024 Apr 1
- The Clinician's Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive Dyskinesia.Shillington, A., LaChappelle, B., Trosch, R., Comella, C., Caroff, S., Ondo, W., Hauser, R., Correll, C., Friedman, J.> ;The Journal of Clinical Psychiatry. 2024 Jan 24
- Join now to see all
Journal Articles
- Therapeutic Strategies for Parkinson Disease: Beyond Dopaminergic DrugsRobert Hauser, MD, Nature
- Deutetrabenazine for Treatment of Involuntary Movements in Patients with Tardive Dyskinesia (AIM-TD): A Double-Blind, Randomised, Placebo-Controlled, Phase 3 TrialHubert H Fernandez, Robert A Hauser, The Lancet
Press Mentions
Pharma Two B Announces Positive Topline Results from Its Pivotal Phase III Study of P2B001 in Early Parkinson's DiseaseDecember 15th, 2021- Anatomy of an Industry: Commerce, Payments to Psychiatrists and Betrayal of the Public GoodSeptember 18th, 2021
- PharmaTher Provides Business Highlights and Releases Annual Financials for Fiscal Year Ended May 31, 2021September 7th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
Tampa General HospitalTampa, Florida
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
